All books in this flagship series contain carefully selected substantial extracts from key cases, legislation, and academic debate, providing students with a stand-alone resource. This chapter examines the law on abortion, beginning with a survey of the ongoing debate over the moral legitimacy of abortion. It then examines the current legal position, and considers how the Abortion Act 1967, as amended, works in practice. It looks at recent controversies over sex-selective abortion and considers the prospects for law reform. Finally, the chapter looks briefly at the regulation of abortion in Northern Ireland, Ireland, and the United States.
Chapter
This chapter examines the law on abortion, beginning with debates over the moral legitimacy of abortion. It then examines the current legal position, and considers how the Abortion Act 1967, as amended, works in practice, as well as considering the prospects for law reform. Finally, the chapter looks briefly at the regulation of abortion in Northern Ireland, Ireland, and the United States.
Chapter
All books in this flagship series contain carefully selected substantial extracts from key cases, legislation, and academic debate, providing students with a stand-alone resource. This chapter examines embryo research, stem cell therapies and other emerging biotechnologies. It begins with a review of philosophical debates over the moral status of the embryo and then discusses regulation in the UK, through the statutory provisions in the Human Fertilisation and Embryology Act 1990, as amended, and the Human Fertilisation and Embryology Authority’s (HFEA) licensing regime. It then turns to consider stem cell therapies, before examining some other emerging biotechnologies, including neurotechnologies and AI, and debates over human enhancement.
Chapter
This chapter covers embryo research, stem cell therapies and other emerging biotechnologies. It begins with a review of philosophical debates over the moral status of the embryo and discusses the regulation of embryo research in the UK. It then turns to consider stem cell therapies, before examining other emerging biotechnologies, including neurotechnologies and AI, and debates over human enhancement.
